NCT05270941

Brief Summary

The aim of this study was to treat the areas with Miller Class I bilateral multiple gingival recession in the maxillary teeth using the Titanium Platelet-Rich Fibrin (T-PRF), an autogenous biomaterial applied in combination with a Modified Coronally Positioned Flap (MCPF) prepared using microsurgical techniques, and the gold standard Subepithelial Connective Tissue Graft (SCTG), to evaluate the efficacy of the treatments and to compare the clinical results 6 months after the treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2019

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 12, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 29, 2020

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2020

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

February 12, 2022

Completed
24 days until next milestone

First Posted

Study publicly available on registry

March 8, 2022

Completed
Last Updated

March 8, 2022

Status Verified

February 1, 2022

Enrollment Period

1.9 years

First QC Date

February 12, 2022

Last Update Submit

February 26, 2022

Conditions

Keywords

recessiongingivalsubepithelial connective tissue graft

Outcome Measures

Primary Outcomes (2)

  • Complete root coverage [ Time Frame: 6 months

    Change from baseline in gingival recession was be assessed at 1, and 6 months.

    6 MONTHS

  • Gingival recession depth [ Time Frame: 6 months ]

    Change from baseline in gingival recession was be assessed at 6 months

    6 months.

Secondary Outcomes (2)

  • Keratinized tissue width [ Time Frame: 6 months ]

    6 months.

  • Pain scores [ Time Frame: first week after operations ]

    first week

Study Arms (2)

Control Groups

ACTIVE COMPARATOR

Control groups. This clinical trial was designed as a split-mouth, randomized, controlled clinical trial. Bilateral gingival recession defects were randomly assigned to the test (CAF+T-PRF) or control (CAF+SCTG) groups after initially evaluating the clinical parameters and randomized by coin flip method. Intervention: Procedure: Control groups

Procedure: COMPARISON OF PLATELET-RICH FIBRIN PREPARED WITH TITANIUM AND SUBEPITHELIAL CONNECTIVE TISSUE GRAFT

Test Group

EXPERIMENTAL

Test groups. This clinical trial was designed as a split-mouth, randomized, controlled clinical trial. Bilateral gingival recession defects were randomly assigned to the test (CAF+T-PRF) or control (CAF+SCTG) groups after initially evaluating the clinical parameters and randomized by coin flip method. Intervention: Procedure: Control groups Intervention: Procedure: test groups

Procedure: COMPARISON OF PLATELET-RICH FIBRIN PREPARED WITH TITANIUM AND SUBEPITHELIAL CONNECTIVE TISSUE GRAFT

Interventions

In the study, 118 maxillary bilateral multiple Miller Class I gingival recessions in 20 patients were treated. The gingival recessions were randomly treated with either T-PRF (58 teeth) or SCTG (60 teeth) using the modified coronally positioned flap technique. Gingival index, plaque index, probing pocket depth, gingival thickness, recession height, recession width, keratinized gingival width, and open root surface area were measured and recorded at baseline and at the 6th month. Postoperative pain levels were evaluated using the VAS (Visual Analogue Scale), and healing status was evaluated using the wound healing index. The pre- and post-treatment results of both treatment groups and the differences between the groups were evaluated and compared.

Also known as: MODİFİYE CORONALLY ADVANCED FLAP
Control GroupsTest Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • the absence of parafunctional habits, non-smoking
  • the presence of Miller Class I gingival recession defect in teeth located in the bilateral maxillary region
  • the absence of any hard tissue defects in the relevant region and the absence of a restorative, endodontic procedure or periodontal surgical intervention
  • a full-mouth plaque score (FMPS) of ≤ 25%
  • having a marginal gingival thickness of at least 1 mm in the area with gingival recession
  • the absence of a shallow hard palate dome
  • having a soft tissue thickness of at least 3 mm
  • the absence of torus in the area where the graft was taken
  • the absence of any systemic disease
  • not using antibiotics for any reason in the last 6 months
  • the presence of at least 20 teeth in the mouth
  • not being pregnant and breastfeeding, and patients who applied to the periodontology clinic with various periodontal problems and were indicated for connective tissue graft operation due to gingival recession

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Necmettin Erbakan Üniversitesi Diş Hekimliği Fakültesi

Konya, Meram, 42050, Turkey (Türkiye)

Location

Necmettin Erbakan Üniversitesi Diş Hekimliği Fakültesi

Konya, 42050, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Gingival Recession

Interventions

Titanium

Condition Hierarchy (Ancestors)

Gingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesPeriodontal Atrophy

Intervention Hierarchy (Ancestors)

Metals, LightElementsInorganic ChemicalsTransition ElementsMetals

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Model Details: As a randomized controlled clinical trial, in the patients' bilateral recession sites, while gingival recessions of one group were treated with T-PRF, the gingival recessions of the other group were treated with SCTG using a simple randomization method.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
dr. öğr. üyesi

Study Record Dates

First Submitted

February 12, 2022

First Posted

March 8, 2022

Study Start

January 12, 2019

Primary Completion

November 29, 2020

Study Completion

November 30, 2020

Last Updated

March 8, 2022

Record last verified: 2022-02

Locations